Lung Cancer
GCT1184-05: A Phase 2, Open-label, Multicohort Study of Rinatabart Sesutecan (Rina-S) in Participants with Non-Small Cell Lung Cancer
- Details
ClinicalTrials.gov ID:
NCT07288177
Diagnosis Type:
NA
USOR Number:
- Address
,
P: